Home › Treatment-Resistant Depressive Disorder › Florida › Tampa
Treatment-Resistant Depressive Disorder clinical trials in Tampa, FL
4 studies for Treatment-Resistant Depressive Disorder are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RecruitingPhase 2
- IPTB Clinical Research, Tampa
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Recruiting
- USF Health, Tampa
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Recruiting
- IPTB Clinical Research, Tampa
- K2 Medical Research, Tampa
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa
Treatment-Resistant Depressive Disorder trials in other cities
- San Diego, CA10 studies
- New York City, NY8 studies
- Houston, TX6 studies
- St. Louis, MO5 studies
- Atlanta, GA5 studies
- Dallas, TX4 studies
- Austin, TX4 studies
- Washington, DC3 studies
- Queens, NY3 studies
- Boston, MA3 studies
- Salt Lake City, UT3 studies
- O'Fallon, MO3 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer34 studies
- Acute Myeloid Leukemia29 studies
- Metastatic Cancer29 studies
- Lung Cancer29 studies
- Pancreatic Cancer26 studies
- Ovarian Cancer21 studies
- Melanoma19 studies
- Myelodysplastic Syndromes19 studies
- Prostate Cancer18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.